Table 1.
Characteristics | Number | RBM15B expression | P value | |
---|---|---|---|---|
High | Low | |||
Gender | 0.6416 | |||
Male | 43 | 22 | 21 | |
Female | 37 | 17 | 20 | |
Age | 0.8161 | |||
<65 | 51 | 25 | 26 | |
≥65 | 29 | 15 | 14 | |
HBV infection | 0.6020 | |||
No | 21 | 10 | 11 | |
Yes | 59 | 32 | 27 | |
AFP | 0.4586 | |||
≤400 (μg/L) | 23 | 10 | 13 | |
>400 (μg/L) | 57 | 30 | 27 | |
Tumour size | 0.0111* | |||
≤5cm | 42 | 18 | 24 | |
>5cm | 38 | 27 | 11 | |
TNM staging | 0.0436* | |||
I-II | 43 | 17 | 26 | |
III-IV | 37 | 23 | 14 | |
Lymph node metastasis | 0.3291 | |||
Absent | 56 | 26 | 30 | |
Present | 24 | 14 | 10 | |
BCLC stage | 0.1227 | |||
Low | 53 | 24 | 29 | |
High | 27 | 16 | 9 | |
PVTT | 0.0070* | |||
NO | 36 | 12 | 24 | |
YES | 44 | 28 | 16 |
*The expression of RBM15B were compared between the tumor tissue and the normal tissue. BCLC, Barcelona Clinic Liver Cancer; PVTT, portal vein tumor thrombus. Italics indicate statistically significant values. *P < 0.05.